Scancell (LON:SCLP) Shares Cross Below Two Hundred Day Moving Average – Should You Sell?

Scancell Holdings plc (LON:SCLP)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 11.90 ($0.15) and traded as low as GBX 8.25 ($0.11). Scancell shares last traded at GBX 8.25 ($0.11), with a volume of 440,305 shares changing hands.

Scancell Stock Down 0.4 %

The company has a market capitalization of £87.69 million, a price-to-earnings ratio of -12.98 and a beta of 0.35. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. The firm’s 50 day simple moving average is GBX 8.94 and its 200-day simple moving average is GBX 11.84.

Scancell (LON:SCLP) last posted its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. On average, sell-side analysts anticipate that Scancell Holdings plc will post -2.5361112 EPS for the current fiscal year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.